SG158077A1 - Novel shuttle vector - Google Patents

Novel shuttle vector

Info

Publication number
SG158077A1
SG158077A1 SG200907759-5A SG2009077595A SG158077A1 SG 158077 A1 SG158077 A1 SG 158077A1 SG 2009077595 A SG2009077595 A SG 2009077595A SG 158077 A1 SG158077 A1 SG 158077A1
Authority
SG
Singapore
Prior art keywords
escherichia coli
region
shuttle vector
ptb6
expression vector
Prior art date
Application number
SG200907759-5A
Other languages
English (en)
Inventor
Kano Yasunobu
Hamaji Yoshinori
Fujimori Minoru
Sasaki Takayuki
Kohno Kyoko
Amano Jun
Taniguchi Shunaeichiro
Original Assignee
Anaeropharma Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anaeropharma Science Inc filed Critical Anaeropharma Science Inc
Publication of SG158077A1 publication Critical patent/SG158077A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Structure Of Belt Conveyors (AREA)
  • Variable-Direction Aerials And Aerial Arrays (AREA)
SG200907759-5A 2004-11-24 2005-11-24 Novel shuttle vector SG158077A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004339677 2004-11-24

Publications (1)

Publication Number Publication Date
SG158077A1 true SG158077A1 (en) 2010-01-29

Family

ID=36498025

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200907759-5A SG158077A1 (en) 2004-11-24 2005-11-24 Novel shuttle vector

Country Status (13)

Country Link
US (1) US8021653B2 (zh)
EP (2) EP1829963A4 (zh)
JP (1) JP4989231B2 (zh)
KR (1) KR101243662B1 (zh)
CN (1) CN101065482B (zh)
AT (1) ATE495246T1 (zh)
CA (1) CA2586126C (zh)
DE (1) DE602005025946D1 (zh)
DK (1) DK2088193T3 (zh)
ES (1) ES2357372T3 (zh)
PT (1) PT2088193E (zh)
SG (1) SG158077A1 (zh)
WO (1) WO2006057289A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911721B2 (en) 2006-05-24 2014-12-16 Anaeropharma Science, Inc. Method of constructing gene transport support
ES2595729T3 (es) * 2007-01-12 2017-01-03 Intrexon Actobiotics Nv Promotores de Lactococcus y usos de los mismos
US9730968B2 (en) 2008-04-17 2017-08-15 Anaeropharma Science, Inc. Therapeutic agent for ischemic diseases
KR101674977B1 (ko) * 2008-04-17 2016-11-10 가부시키가이샤 아네로파마·사이엔스 발현 벡터
JP5836129B2 (ja) 2010-01-29 2015-12-24 株式会社アネロファーマ・サイエンス 形質転換用プラスミド
EP3105254B1 (en) 2014-02-14 2019-11-20 Symvivo Corporation Hybrid proteins and uses thereof
CN104388419B (zh) * 2014-10-13 2018-01-16 华侨大学 一种高效扩增核酸分子的方法
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
RU2749717C2 (ru) * 2015-11-24 2021-06-16 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Способ временной трансфекции для продуцирования ретровируса
CA3006288A1 (en) * 2015-11-24 2017-06-01 Glaxosmithkline Intellectual Property Development Limited Stable cell lines for retroviral production
KR20170068304A (ko) 2015-12-09 2017-06-19 삼성전자주식회사 대장균 및 코마가타에이박터 속 세포에서 복제가능한 벡터, 그를 포함한 세포, 및 그를 이용하는 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63309191A (ja) * 1987-06-09 1988-12-16 Toagosei Chem Ind Co Ltd プラスミドベクタ−
US6110737A (en) 1988-02-02 2000-08-29 The Regents Of The University Of California Human platelet-derived growth factor receptor, type A
JPH05130876A (ja) * 1991-04-10 1993-05-28 Morinaga Milk Ind Co Ltd プラスミドベクター
US6190657B1 (en) 1995-06-07 2001-02-20 Yale University Vectors for the diagnosis and treatment of solid tumors including melanoma
JP3946300B2 (ja) * 1997-03-27 2007-07-18 株式会社ヤクルト本社 ビフィズス菌用シャトルベクター及びビフィズス菌プラスミドの複製タンパク質遺伝子
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
EP1012232B1 (en) 1997-09-10 2009-10-28 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
JPH11285387A (ja) * 1998-04-03 1999-10-19 Tdk Corp 新規なｄｎａ配列及びそれを含むプラスミドベクター
AU7572900A (en) 1999-08-26 2001-03-19 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
JP3642755B2 (ja) 2000-09-21 2005-04-27 純 天野 嫌気性菌を用いた遺伝子治療用医薬
CA2342040C (en) 2000-09-21 2012-07-10 Kyowa Hakko Kogyo Co., Ltd. Anaerobic bacterium as a drug for cancer gene therapy
EP1386006B1 (en) * 2001-04-20 2008-05-28 The Penn State Research Foundation Methods for nucleic acid manipulation
JP2003235565A (ja) * 2002-02-20 2003-08-26 Yakult Honsha Co Ltd 乳酸菌用シャトルベクター

Also Published As

Publication number Publication date
CA2586126A1 (en) 2006-06-01
EP1829963A4 (en) 2009-01-28
EP2088193A1 (en) 2009-08-12
JP4989231B2 (ja) 2012-08-01
KR101243662B1 (ko) 2013-03-14
ATE495246T1 (de) 2011-01-15
ES2357372T3 (es) 2011-04-25
CN101065482A (zh) 2007-10-31
CN101065482B (zh) 2011-07-13
US20100129323A1 (en) 2010-05-27
KR20070107671A (ko) 2007-11-07
WO2006057289A1 (ja) 2006-06-01
CA2586126C (en) 2016-06-28
EP2088193B1 (en) 2011-01-12
EP1829963A1 (en) 2007-09-05
US8021653B2 (en) 2011-09-20
JPWO2006057289A1 (ja) 2008-06-05
DK2088193T3 (da) 2011-02-28
DE602005025946D1 (de) 2011-02-24
PT2088193E (pt) 2011-02-24

Similar Documents

Publication Publication Date Title
SG158077A1 (en) Novel shuttle vector
CA2274982A1 (en) New escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy
TNSN03116A1 (en) Pulmonary administration of chemically modified insulin
Römling et al. Progress in understanding the molecular basis underlying functional diversification of cyclic dinucleotide turnover proteins
Howard et al. Color selection with a hygromycin-resistance-based Escherichia coli-mycobacterial shuttle vector
AU2002233186A1 (en) Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
AU2003302250B2 (en) IL-21 production in prokaryotic hosts
IL156111A0 (en) Bacterial host strains
MX2010002001A (es) Peptido cdca1 y agente farmaceutico que comprende elmismo.
CA2446776A1 (en) Self-containing lactococcus strain
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
HK1068797A1 (en) Use of long pentraxin ptx3 in the manufacture of amedicament for increasing reproductive ability in a female
MX2021011418A (es) Metodos de produccion de bioconjugados de polisacaridos de e. coli o- antigeno, sus composiciones y metodos de utilizacion.
CA2342040A1 (en) Anaerobic bacterium as a drug for cancer gene therapy
NZ507077A (en) A vaccine comprising a bacterium that has an aroC/ompF/ompC combination mutation and optionally a mutation in a fourth gene
UA85365C2 (ru) Продукт конъюгирования цитокина для использования в противораковой терапии
WO2000044906A3 (en) GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
GB0121998D0 (en) Attenuated bacteria useful in vaccines
GB2437686A (en) Listeriolysin-containing bacillus spores as antigen delivery agents
Sanders et al. Membrane-spanning and periplasmic segments of CcmI have distinct functions during cytochrome c biogenesis in Rhodobacter capsulatus
Hosseini et al. Targeting of cholera toxin A (ctxA) gene by zinc finger nuclease: pitfalls of using gene editing tools in prokaryotes
IL151527A (en) Mutated cyclin g1 protein
YU8402A (sh) Gen streptomyces avermitilis koji usmerava odnos b2:b1 avermektina
PT1673391E (pt) Cdna modificado para elevados níveis de expressão do factor viii e dos seus derivados
WO2001034810A3 (en) Genes essential for microbial proliferation